Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia

Abstract Background Chronic myeloid leukemia (CML) relapse and progression after discontinuation of tyrosine kinase inhibitors (TKI) therapy in the chronic phase (CP) are attributed to primitive quiescent leukemic progenitor cells (LPCs). This study aimed to identify key differentially expressed gen...

Full description

Saved in:
Bibliographic Details
Main Authors: Alvea Tasneem, Archana Sharma, Mansoor Ali Syed, Ravins Dohare
Format: Article
Language:English
Published: SpringerOpen 2024-12-01
Series:Egyptian Journal of Medical Human Genetics
Subjects:
Online Access:https://doi.org/10.1186/s43042-024-00614-2
Tags: Add Tag
No Tags, Be the first to tag this record!